Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.6122
+0.01895 (3.19%)
At close: Jun 4, 2026
RVPH Market Cap
RVPH has a market cap or net worth of $8.03 million as of June 4, 2026. Its market cap has decreased by -83.49% in one year.
Market Cap
8.03M
Enterprise Value
-13.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.61
Market Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from 25.21M to 8.03M, a decrease of -68.16%. That is a compound annual growth rate of -13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 8.03M | -75.38% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 12.13M |
| Finch Therapeutics Group | 11.96M |
| Biomind Labs | 9.31M |
| Brainstorm Cell Therapeutics | 8.75M |
| Synlogic | 8.19M |
| Adaptimmune Therapeutics | 7.95M |
| TRON Group | 7.89M |
| NKGen Biotech | 7.84M |